Moderna (MRNA) closed at $34.01 in the latest trading session, marking a -1.9% move from the prior day. This change lagged the S&P 500's daily gain of 0.07%. Meanwhile, the Dow lost 0.7%, and the ...

Robert F. Kennedy Jr.’s leadership at Health and Human Services has led to changes in vaccine recommendations and access, ...

Thursday, July 24, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Cisco Systems ...

American Airlines is on track to regain its historical levels of revenue share from indirect channels by the end of the year, CEO Robert Isom said Thursday during the carrier's second-quarter ...

The researcher has penned crime novels full of death — and received more than $5.8 million from the European Union toward ...

In experiments conducted in a biosafety level 3 facility, the researchers studied ferrets that had antibodies to seasonal flu ...

Researchers at the University of Florida have developed a new mRNA-based vaccine that, when combined with checkpoint ...

The chief engine of the U.S. economy lies in intangible investments, such as research and development, software, ...

Scientists have discovered that Pfizer's COVID-19 vaccine may increase the risk of eye damage, leading to vision loss.The new study specifically examined how ...

Speaking at the Capital Framework for Large Banks conference at the Federal Reserve Board of Governors, Altman addressed one ...

The risk for respiratory syncytial virus-related hospitalizations is elevated in children with chronic medical conditions ...

You should consider the Invesco S&P 500 Equal Weight Health Care ETF (RSPH), a passively managed exchange traded fund launched on 11/01/2006. An increasingly popular option among retail and ...